Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Weston P Miller"'
Autor:
Troy C Lund, Paul S Stadem, Angela Panoskaltsis-Mortari, Gerald Raymond, Weston P Miller, Jakub Tolar, Paul J Orchard
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e32218 (2012)
BackgroundX-linked adrenoleukodystrophy (ALD) is a metabolic, peroxisomal disease that results from a mutation in the ABCD1 gene. The most severe course of ALD progression is the cerebral inflammatory and demyelinating form of the disease, cALD. To d
Externí odkaz:
https://doaj.org/article/54b0c4fa51ac4e8bb4b17460f9972de5
Autor:
Kathryn A Thibert, Gerald V Raymond, David R Nascene, Weston P Miller, Jakub Tolar, Paul J Orchard, Troy C Lund
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e50430 (2012)
X-linked adrenoleukodystrophy results from mutations in the ABCD1 gene disrupting the metabolism of very-long-chain fatty acids. The most serious form of ALD, cerebral adrenoleukodystrophy (cALD), causes neuroinflammation and demyelination. Neuroimag
Externí odkaz:
https://doaj.org/article/ed5bc9d739fa49a28aa2472305bae472
Autor:
Julie B. Eisengart, David Nascene, Daniel L. Kenney-Jung, Elizabeth I. Pierpont, Troy C. Lund, Paul J. Orchard, Ryan Shanley, Ashish Gupta, Weston P. Miller, Richard S. Ziegler
Publikováno v:
Neurology
article-version (Version of Record) 3
article-version (Version of Record) 3
ObjectiveTo quantify benchmark treatment outcomes that may be enabled by newborn screening surveillance for X-linked adrenoleukodystrophy (ALD), we report neurocognitive, neuropsychiatric, and MRI change for boys who underwent hematopoietic stem cell
Autor:
Troy C. Lund, Daniel J. Loes, Ashish Gupta, Gerald V. Raymond, Dave R. Nascene, Paul J. Orchard, David H. McKenna, Weston P. Miller
Publikováno v:
Stem Cells Translational Medicine
Stem Cells Translational Medicine, Vol 9, Iss 5, Pp 554-558 (2020)
Stem Cells Translational Medicine, Vol 9, Iss 5, Pp 554-558 (2020)
Cerebral adrenoleukodystrophy is an inflammatory demyelinating condition that is the result of a mutation in the X‐linked ABCD1 gene, a peroxisomal very long chain fatty acid transporter. Although mutations in this gene result in adrenal insufficie
Autor:
Andrew Nguyen, Weston P. Miller, Ashish Gupta, Troy C. Lund, Daniel Schiferl, Lok Sze Kelvin Lam, Zorayr Arzumanyan, Paul J. Orchard, Lynda E. Polgreen
Publikováno v:
JBMR plus. 6(3)
The only treatment currently available for patients with severe infantile osteopetrosis is hematopoietic cell transplantation (HCT). HCT-related toxicity and mortality risks typically preclude its use in non-infantile patients, and other therapies ar
Autor:
Holly Winslow, Weston P. Miller, Ashish Gupta, Daniel L. Kenney-Jung, Gerald Raymond, Heather Zierhut, Susan A. Berry, Amy Hietala, Troy C. Lund, Paul J. Orchard, Hyoung Gwon Choi, Elizabeth I. Pierpont, Katie Wiens, Amy Gaviglio
Publikováno v:
American Journal of Medical Genetics. Part a
Minnesota became the fourth state to begin newborn screening (NBS) for X‐linked adrenoleukodystrophy (X‐ALD) in 2017. As there is limited retrospective data available on NBS for X‐ALD, we analyzed Minnesota's NBS results from the first year of
Autor:
Ashish Gupta, Paul J. Orchard, Troy C. Lund, Daniel L. Kenney-Jung, Weston P. Miller, David Nascene
Publikováno v:
Blood. 133:1378-1381
Adrenoleukodystrophy (ALD) is caused by mutations within the X-linked ABCD1 gene, resulting in the inability to transport acylated very long chain fatty acids (VLCFAs) into the peroxisome for degradation. VLCFAs subsequently accumulate in tissues, in
Autor:
Maria L. Escolar, Susan Paadre, Asif M. Paker, Jean Hugues Dalle, Joanne Kurtzberg, Vinod K. Prasad, Paul J. Orchard, John J Balser, Gerald V. Raymond, Alain Fischer, Weston P. Miller, Patrick Aubourg, André Baruchel, David Nascene, Troy C. Lund, Stéphane Blanche, Gérard Michel
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:538-548
Cerebral adrenoleukodystrophy (CALD) is a rapidly progressing, often fatal neurodegenerative disease caused by mutations in the ABCD1 gene, resulting in deficiency of ALD protein. Clinical benefit has been reported following allogeneic hematopoietic
Publikováno v:
Transplantation and cellular therapy. 27(1)
We report the outcomes of cord blood transplantation (CBT) with a busulfan (Bu) pharmacokinetics-targeted myeloablative conditioning regimen in 97 children with Hurler syndrome (HS) performed between 2004 and 2016. The median age at CBT was 10.8 mont
Publikováno v:
J Pediatr Neurol
X-linked adrenoleukodystrophy (ALD) is a neurodegenerative peroxisomal disorder with variable clinical phenotypes. Childhood cerebral ALD (CCALD) is at the most severe end of the disease spectrum. In CCALD, the clinical manifestations include increas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3536f0f66b876466eea63511fec169f0
https://europepmc.org/articles/PMC7410095/
https://europepmc.org/articles/PMC7410095/